US Broker Ratings

Agilent Technologies (A) Stock Analysis: Unpacking Growth Potential and Analyst Ratings

Agilent Technologies, Inc. (NYSE: A) stands as a prominent player in the healthcare sector, particularly within the diagnostics and research industry. Headquartered in Santa Clara, California,..

BeOne Medicines Ltd. (ONC) Stock Analysis: Strong Buy Ratings and 15.58% Potential Upside for Investors

BeOne Medicines Ltd. (ONC), a Swiss-based oncology powerhouse, is capturing significant investor interest in the biotechnology sector, primarily due to its innovative cancer treatments and strong..

Humana Inc. (HUM) Stock Analysis: Is There a 10.2% Upside in Healthcare Plans?

For investors eyeing the healthcare sector, Humana Inc. (NYSE: HUM) presents a compelling case with its robust market presence and a potential upside of 10.2% based..

Vertex Pharmaceuticals (VRTX) Stock Analysis: Assessing Growth Potential with 9% Upside

Vertex Pharmaceuticals Incorporated (NASDAQ: VRTX) stands out in the biotechnology sector with a robust market capitalization of $132.71 billion, placing it among the giants in its..

Elevance Health, Inc. (ELV) Stock Analysis: Exploring a 9.44% Potential Upside in the Healthcare Sector

Elevance Health, Inc. (NYSE: ELV), a titan in the healthcare plans industry, offers a compelling opportunity for investors looking to tap into the stability and growth..

GE HealthCare Technologies Inc. (GEHC) Investor Outlook: Assessing a 15.75% Upside Potential

For investors with an eye on the healthcare sector, GE HealthCare Technologies Inc. (NYSE: GEHC) presents an intriguing prospect. As a pivotal player in the medical..

Johnson & Johnson (JNJ) Stock Analysis: Balancing Robust Growth with a 2.03% Dividend Yield

Johnson & Johnson (NYSE: JNJ), a titan in the healthcare sector, remains a formidable player with a market capitalization of $635.07 billion. Known for its diverse..

Amgen Inc. (AMGN) Investor Outlook: A Healthcare Giant with High Return on Equity and a Solid Dividend Yield

Amgen Inc. (NASDAQ: AMGN) remains a formidable player in the healthcare sector, particularly in the general drug manufacturing industry. With a robust market capitalization of $237.48..

Gilead Sciences, Inc. (GILD) Stock Analysis: Evaluating Growth Potential Amidst a Robust Pipeline

Gilead Sciences, Inc. (NASDAQ: GILD), a renowned player in the healthcare sector, is known for its extensive biopharmaceutical innovations. The company specializes in developing and commercializing..

Merck & Company, Inc. (MRK) Stock Analysis: Strong Buy Consensus and Nearly 10% Potential Upside

Merck & Company, Inc. (NYSE: MRK) has long stood as a stalwart in the healthcare industry, renowned for its innovative pharmaceutical solutions and robust pipeline. With..

Eli Lilly (LLY) Stock Analysis: Robust Growth and Strategic Collaborations Fuel Investor Optimism

Eli Lilly and Company (NYSE: LLY), a titan in the healthcare sector, continues to capture investor attention with its impressive market cap of $1.14 trillion. As..

Oruka Therapeutics, Inc. (ORKA): Investor Outlook Reveals Potential 91% Upside in Biotech Breakthrough

Oruka Therapeutics, Inc. (NASDAQ: ORKA), a burgeoning entity within the biotechnology sector, is catching the eye of investors with a compelling potential upside of 91%. Headquartered..

Rapport Therapeutics, Inc. (RAPP) Stock Analysis: Unpacking a 161.58% Potential Upside

Rapport Therapeutics, Inc. (NASDAQ: RAPP), a clinical-stage biopharmaceutical company, has captured the attention of investors with its promising pipeline and significant potential upside. Specializing in the..

Prothena Corporation plc (PRTA) Stock Analysis: A Biotech Gem with 159% Upside Potential

For investors with a keen interest in biotechnology, Prothena Corporation plc (NASDAQ: PRTA) presents a compelling opportunity. Based in Dublin, Ireland, Prothena is a late-stage clinical..

Emergent BioSolutions Inc. (EBS) Stock Analysis: Exploring a 76% Upside Potential

Emergent BioSolutions Inc. (NYSE: EBS) stands at an intriguing crossroads for investors seeking opportunities within the healthcare sector. As a key player in the specialty and..

Myriad Genetics, Inc. (MYGN) Stock Analysis: Navigating Challenges with Strategic Alliances

Myriad Genetics, Inc. (NASDAQ: MYGN), a pioneering force in the molecular diagnostics and precision medicine industry, presents a complex picture for investors as it navigates a..

Treace Medical Concepts, Inc. (TMCI) Stock Analysis: Evaluating a Potential 28.50% Upside Amidst Challenging Metrics

Treace Medical Concepts, Inc. (NASDAQ: TMCI), a prominent player in the healthcare sector, specializes in medical devices designed to address complex surgical needs, particularly in bunion..

Castle Biosciences, Inc. (CSTL) Stock Analysis: Exploring a 36% Upside with Strong Buy Ratings

Castle Biosciences, Inc. (NASDAQ: CSTL) stands as a compelling opportunity within the healthcare sector, specifically in the diagnostics and research industry. Headquartered in Friendswood, Texas, this..

Oric Pharmaceuticals, Inc. (ORIC) Stock Analysis: 58.79% Potential Upside Targets Biotech Enthusiasts

Oric Pharmaceuticals, Inc. (NASDAQ: ORIC) is capturing the attention of investors with its bold strides in the biotechnology sector. With a market capitalization of $1.41 billion,..

SIGA Technologies Inc. (SIGA) Stock Analysis: Healthcare Innovator at a Crossroads

SIGA Technologies Inc. (NASDAQ: SIGA), a notable entity within the healthcare sector, resides in the highly specialized industry of drug manufacturing, with a focus on specialty..

Search

Funds

US Broker Ratings

Search

Funds

US Broker Ratings

FTSE 100

Funds